| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |